Although IL-17A inhibitors were not used in this case, making it difficult to compare the efficacy of IL-17A monotherapy versus IL-17A/F dual inhibition, IL-17 inhibition may represent a rational therapeutic approach for superimposed linear psoriasis. This evidence concerns the gene IL17A and psoriasis.